The Significance of the New H5N1 Bird Flu Outbreak and Its Impact on Human Health

H5N1 as a Global Threat

The highly pathogenic avian influenza (HPAI) virus known as H5N1 first emerged in 1997 and has continued spreading globally. Carried between continents by migratory birds, it has caused serious losses in poultry and wildlife. The H5N1 clade 2.3.4.4b that emerged in 2021 attracted attention as a variant capable of infecting terrestrial and marine mammals as well as birds. In early 2024, infection was detected in dairy cattle in the United States for the first time. This spread increases human exposure to H5N1 and the threat to health. With cases rising in the United States, NEJM published an important article on December 31 titled “The Emerging Threat of H5N1 to Human Health”. The discussion below is based on that article.

H5N1 is an influenza A subtype. As highly pathogenic avian influenza, it is classified as H5N1, influenza A (HPAI A/H5N1) in this terminology.

• Influenza A: A broad group of viruses that can infect humans, birds, pigs, and other animals. Types capable of causing pandemics belong to this group.
• Influenza B: Infects only humans and causes seasonal influenza. It is generally milder and does not cause pandemics.
• Influenza C: Causes mild respiratory infections and is uncommon.
• Influenza D: Occurs in cattle, with no reported human infections.

In other words, H5N1 = Influenza A , the viral family to which this bird-flu subtype belongs.

H5N1 has previously caused severe human cases but has not caused a major pandemic. There are several main reasons:

• H5N1 does not readily infect humans
  • Human H5N1 infection generally requires direct contact with infected birds.
  • The virus does not spread easily between people, unlike a rapidly transmitted respiratory virus such as COVID-19.
• Cases have generally remained limited
  • According to World Health Organization (WHO) data, more than 860 people have contracted H5N1 since 1997, and 50% have died.
  • Most cases, however, occurred in people with direct animal contact.
  • Because person-to-person transmission is rare, the virus has not caused large outbreaks.
• New mutations may increase the risk
  • The latest H5N1 variant, clade 2.3.4.4b, can now infect mammals, including cattle and cats.
  • Mutations that may improve adaptation to humans were identified in the Canadian case.
  • If H5N1 gains the ability to spread between people, it could become a global pandemic like COVID-19.

In summary: H5N1 has not caused a major human outbreak because it did not spread easily between people. Recent mutations suggest that this could change, so scientists are monitoring it closely.

H5N1 in Humans: New Cases and Clinical Findings

Human Cases in the United States and Canada

Recent human H5N1 infections have been reported in the United States and Canada. Most of the 46 reported United States cases were mild:

• 20 people had poultry exposure,
• 25 had dairy cattle exposure,
• 1 had an unknown source of infection.

Most had worked without personal protective equipment (PPE), and symptoms were generally mild. The most common were:

• Conjunctivitis (eye infection)
• Fever in half of patients
• Mild respiratory symptoms in a small number

All recovered, and only one was hospitalized; that admission was reportedly not for a respiratory infection.

In Canada, a 13-year-old girl with asthma developed respiratory failure from H5N1 infection and required intubation and venovenous extracorporeal membrane oxygenation (ECMO). Treatment included oseltamivir (Enfluvir, Oseflu), amantadine, and baloxavir, and she recovered. Viral samples nevertheless contained mutations that might increase adaptation to humans:

• E627K (in the polymerase basic 2 gene)
• E186D and Q222H (in the H5 hemagglutinin gene)

It is unclear whether these mutations existed before infection or arose during illness, but they may increase the possibility of easier human transmission.

Key Human Health Issues in the H5N1 Outbreak

1. Cooperation Between Human and Veterinary Health

Detecting H5N1 requires cooperation among veterinarians, public health specialists, and clinicians. Surveillance programs in the United States enabled early identification and management. The One Health approach is particularly important for zoonotic infections such as bird flu.

2. Monitoring Mutations and Human Transmission Risk

The mutations in the Canadian case may represent H5N1 changes that make human infection easier . More genetic data and epidemiological analysis are needed to understand viral evolution. Unfortunately, animal viral samples often lack sufficient data to establish transmission dynamics fully.

3. Vaccine and Antiviral Development

Existing vaccines developed for H5N1 have shown laboratory effectiveness against the virus . However, two doses are recommended for effectiveness. Work is continuing on H5N1 mRNA-based vaccines and other innovative vaccine technologies.

Existing antivirals, including oseltamivir, amantadine, and baloxavir, also appear effective against the virus. However, high viral loads and prolonged shedding in some cases may require longer treatment courses.

The United States Centers for Disease Control and Prevention (CDC) recommends extended oseltamivir treatment in severe H5N1 cases.

Baloxavir should not be used alone in hospitalized patients because of resistance risk.

4. Preventing Infection and Using PPE

Personal protective equipment (PPE) is particularly important for people in contact with animals. However, using it on dairy and poultry farms presents challenges:

• Dust, milk, and feathers can easily contaminate the environment.
• High temperatures may make PPE difficult to use.
• Large fans may spread airborne particles.

Hygiene measures therefore need improvement, and PPE use should be encouraged.

Potential Future Dangers of H5N1

The true threat H5N1 poses to human health is not yet fully understood. Historically, H5N1 has had a case fatality rate of approximately 50% . However, milder North American cases suggest that the virus has evolved into a different form .

The CDC currently considers H5N1 a low risk to the general public. However, increasing reports in recent weeks and cases with unknown infection sources indicate that its potential for human-to-human transmission needs close monitoring.

In conclusion, although the risk of H5N1 transmission to humans is low, its potential to mutate means continuous surveillance and vaccine development must continue without delay.

Recommendation: People working with livestock, in particular, should use PPE carefully, and anyone with influenza-like symptoms should seek medical care promptly. Public health specialists should monitor mutations regularly and respond quickly to a potential outbreak.

Influenza in Turkey

According to Turkey's Ministry of Health, seasonal influenza is occurring this year as it does annually. Case numbers and growth rates resemble previous years, with no exceptional changes in virus types or positivity rates. Approximately half of circulating influenza viruses are influenza A (H1N1, swine flu) . The current situation is therefore considered seasonal influenza. 

Influenza Outbreaks in Europe

Europe is experiencing a marked increase in influenza. Outbreaks in countries such as Spain and Hungary have placed pressure on healthcare systems. Cases are rising rapidly in Spain, while Hungary is introducing stricter measures. 

Conclusions and Recommendations

Seasonal influenza in Turkey is currently following its usual pattern, while some European regions are experiencing outbreaks. People in higher-risk groups should therefore receive influenza vaccination and follow hygiene measures.